A demand, competition, search and pricing scan for Peninsula Center of Cosmetic Dentistry, Los Altos and Mountain View. Built on US Census ACS 2024, CDC NHANES, directly counted chain locators, ADA workforce data, a 26 provider local roster and paid search benchmarks.
The opportunity is real and it is large in dollars. It is not large in patient counts, and the earlier framing of an aging, under-served market does not survive the census data. What makes this market attractive is concentrated wealth, a thin branded full-arch supply, and the fact that PCCD does not currently compete for the category at all.
Real, but a value market not a volume market
The trade area is younger than the US (15.1% aged 65+ versus 17.2%) and its affluence suppresses tooth loss to roughly 0.68x the national rate. Fewer candidates per capita, but with the highest willingness to pay in the country.
Fragmented and local, not consolidated and national
The Bay Area is one of the densest general dental markets in America yet among the least penetrated by full-arch chains. The real threat is 26 local independents, ten of whom market full-arch. Two sit within 0.1 miles of PCCD.
Tier 1 clinical stack, Tier 3 marketing
Highest rating in the roster at 4.9 on 391 Google reviews, plus DSD certification, an in-house ceramic lab, IV sedation and in-house bone grafting. Surgery will be done in house, so the full case value stays in the practice. And today, zero full-arch demand capture.
Thesis in one line. PCCD already owns the hardest things to build, which are trust, craft and a premium brand. It is missing the easiest thing to build, which is the vocabulary patients actually search. The category is not empty and it is not cheap to enter, so the win is not "we do full arch" but a concierge position that exactly one other practice in the metro occupies, backed by a price that is publicly justified rather than hidden.
Four PCCD service pages were read directly. The terms patients search for full-arch treatment do not appear anywhere on the site.
Searched across PCCD service pages, September 2026
| Term patients search | Appears on PCCD site |
|---|---|
| All-on-4 | No |
| All-on-X | No |
| Full arch | No |
| Teeth in a day | No |
| Published pricing | No |
| Surgical credential asserted | No |
The language is single tooth and cosmetic, not edentulous
The Full Mouth Reconstruction page describes restoring both jaws but is illustrated entirely with veneer cases of 4, 20 and 28 units. It is a cosmetic dentition page, not a page for a patient losing their teeth.
The consequence. Roughly 40 of the 70 local providers profiled here market All-on-4 or All-on-X explicitly. Two of them sit within 0.1 miles of PCCD's Los Altos office. A 537 review implant center thirteen miles away runs a landing page titled "Dental Implants Los Altos", buying PCCD's own city name. PCCD competes for none of it. Because so many already claim the category, PCCD's differentiation cannot be "we do full arch", it has to be the position and the proof.
These two facts point in opposite directions and should not be collapsed. General dental supply here is near the top of the country. Branded full-arch supply is near the bottom. Chain counts below were parsed directly from company locators, 105 ClearChoice and 56 Nuvia centers verified individually.
ClearChoice plus Nuvia centers per million residents aged 65 plus. Lower means less penetrated, which means more open. San Jose is highlighted.
Dentists per 100,000 population, ADA Health Policy Institute 2025
Marketed ranges and state averages, not transacted fees. Bay Area carries a 15 to 30 percent premium.
Share of reachable dental practice websites inside identically sized bounding boxes that market All-on-4, All-on-X or teeth in a day. Measured by direct crawl, September 2026.
Silicon Valley has the most dentists of the three metros, 662 mapped versus 304 in Phoenix, yet the lowest share marketing full-arch. Phoenix is saturated at nearly six in ten. This is a crawl sample, so absolute counts understate the market; the rates are the comparable part.
San Francisco is the most expensive dental paid search market in the US. Modeled figures, use for relative comparison only.
Same market, opposite answers depending on the question
| Question | Answer | Evidence |
|---|---|---|
| Is general dentistry crowded here? | Yes, top tier | CA #4 of 51; Santa Clara 127.8 per 100K |
| Is branded full-arch crowded here? | No, 13th of 15 | 3.43 centers per 1M seniors |
| Is it expensive to compete? | Most in the US | $12.56 CPC versus $7.85 national |
| Can you charge for it? | Highest in the US | $30.5K per arch versus $23.5K national |
| Who is the real threat? | Local independents | 26 providers, 10 marketing full-arch |
Why the chains are thin here, and why that matters. National full-arch chains optimize for cheap real estate, lower labor cost and older lower income populations that convert on volume financing. The Bay Area inverts all four. That explains chain absence but it does not mean absent competition. The gap is filled by independent implantologists, periodontists and oral surgeons who appear in no chain locator, and the local roster below measures exactly that layer. The practical consequence is that the volume financing players who would compress price are largely absent, which favors a differentiated premium position over a price led one.
Review counts below are stated with their platform named, because mixing a cross platform aggregate with a Google count produces a false comparison. The previous version of this report made exactly that error. The roster table shows the 26 providers verified in detail; a further sweep identified roughly 70 in total across the twenty mile ring.
Data quality warning on every rating in this section. No rating here was confirmed on Google or Yelp directly, because Google Maps, Yelp, Bing and Healthgrades all block automated reads. The counts shown come from aggregator profiles that explicitly attribute the number to Google, which is the best available basis but is not the same as reading Google. A Google Places API pass is required before any rating in this report is shown to a client. No Yelp star rating exists anywhere in this analysis, including PCCD's.
Google attributed counts only, observed September 23 2026. PCCD is both locations combined.
How the 26 providers split on whether they market the category at all
Tier 1 pairs branded language with technology proof and high review volume. Tier 3 has the clinical capability and no marketing. PCCD sits in Tier 3.
The geographic squeeze. PCCD's two nearest competitors are roughly 400 feet away. Mid-Peninsula Dental Specialists holds 5.0 on 144 Google reviews with perio, prostho and oral surgery under one roof. Legacy Dental, owned by Dr. Jeffrey Diamond, holds 4.9 on 123 Google reviews and runs a dedicated All-on-Four page for Los Altos. Neither is a distant threat.
Rows marked unverified were carried from the previous internal file and their review platform is unknown. They need re-verification before being charted. Distances are estimates.
The roster splits into two different things, and this is the most useful finding in the section. About 16 Tier 1 brands are buying the terminology and anchoring price, and those are PCCD's real paid search competition. The roughly 19 Tier 2 specialists are a partnership map, not a competitive set. Two examples sit almost next door: a periodontist 0.7 miles away rated 4.9 on 58 Google reviews who does no full-arch marketing at all, and an oral surgeon 2.2 miles away rated 4.8 on 167 reviews who is an associate professor of oral surgery teaching implant placement. Neither competes for the brand. Either could supply the surgical leg PCCD has never asserted.
US Census ACS 2024 five year estimates across sixteen geographies. The affluence is genuinely exceptional. The age profile is not, and that correction matters for every volume estimate downstream.
Mean household income. Use this rather than median, because six of sixteen geographies hit the ACS top-code ceiling and become indistinguishable.
The immediate trade area towns are old. The wider trade area is not.
Read the two charts together. Los Altos Hills at 30.9%, Saratoga 26.5%, Atherton 25.6% and Los Altos 20.8% are genuinely older than the US. But Mountain View at 12.0%, Santa Clara at 11.4% and Sunnyvale at 13.0% pull the combined trade area to 15.1%, which is younger than the national 17.2%. The concentration of affluent seniors is what is exceptional here, at 3.5x the US rate, not the raw count of seniors.
Values marked with a ceiling symbol are ACS top codes, not measured values. Income caps at $250,001 and home value at $2,000,001. Do not rank markets on those columns. Atherton is directional only given its small household count.
Tooth loss is driven far more by education and income than by age. Applying a national rate to one of the most educated and highest income trade areas in the country would overstate the candidate pool by 30 to 45 percent. Here is the correct stratum and the full calculation.
Complete tooth loss, NHANES 2017 to March 2020, CDC 2024 Oral Health Surveillance Report
This is the finding that reframes the opportunity. The correct stratum for this trade area is the rightmost bar.
Ten cities within roughly ten miles of downtown Los Altos. Each step is labeled measured or estimated.
Two warnings that must travel with these numbers. First, the final figure is a prevalence pool, a stock, not annual demand. Only a small single digit percentage of it converts in any year, so it must never be presented as an annual market. Second, the arch candidacy multiplier of 2 to 3 times is unsourced. It is conventional practice to account for terminal dentition and single arch cases, but it could not be verified and should be treated as a placeholder until it is.
What this means strategically. A model built on volume assumptions will disappoint here. A model built on case value, conversion quality and aesthetic outcome will not. That maps precisely onto what PCCD already has, which is DSD certification, an in-house ceramic lab, IV sedation and the highest rating in the market.
The standard implant deck leans on an aging population. That argument is weaker than it looks. The real story is that implants remain badly under-adopted relative to need and relative to peer countries, and that full-arch grows about one and a half times the base market.
Share of US adults with at least one missing tooth who have at least one implant. NHANES, seven waves, Elani et al.
Covariate adjusted growth of 14 percent per year. The authors' central projection for 2026 is 17 percent. The widely quoted 23 percent is their most aggressive of four scenarios and should not be presented as fact.
No published US full-arch market series exists. Four unrelated segment proxies independently converge on 11 to 14 percent against a 7 to 8 percent base.
That four independent proxies agree on the magnitude is itself the finding. Any single quoted full-arch market size is an extrapolation.
Edentulous Americans aged 65 plus, millions, under two published models
The rate falls while the base grows, so the absolute count plateaus rather than booms. Honest statement: roughly 9 to 11 million edentulous seniors in 2040 against about 8.6 million today.
For PCCD this points at partial and single arch cases in dentate patients, which is also where its cosmetic brand and DSD workflow are strongest.
The pressure behind the category. General practitioner net income fell 13.2 percent in real terms between the 2015 to 2019 and 2020 to 2024 periods while expenses rose 3.0 percent, and DSO affiliation more than doubled from 7.2 percent of dentists in 2015 to 16.1 percent in 2024, reaching 31 percent among dentists less than five years out of school. High ticket full-arch is the pressure valve the profession is reaching for, which is why the category is getting more crowded even where patient volume is not growing.
Implant search demand is growing but the growth has moved into the modifier tail, meaning cost, financing, same day and near me queries rather than the head term. Implants are the most expensive category in dental paid search and convert worse than general dentistry, which is the defining economic tension.
Modeled index anchored on one measured point, a 22.2 percent rise from 2021 to 2022. This is a direction, not a measured Google Trends series.
Modeled monthly index, mean of 100. Search peaks in January on benefit reset. Consultations peak in December on benefit expiry.
US monthly search volume. The All-on-4 term alone carries 40,500 searches a month.
Measured account data, Delmain 2026, 187 campaigns. Implants combine a high click cost with the second worst conversion rate.
Patients compare three to five providers before calling, and 15 to 20 percent of non responders book after six weeks or more. Speed to lead matters enormously, with conversion dropping sharply if contact is not made within five minutes. This is a category won on follow up discipline, not on a single ad impression.
The Bay Area carries the highest full-arch pricing in the country. Against that, even an expensive acquisition cost returns a large multiple, which is exactly why click prices sustain at these levels.
Estimated Bay Area full-arch acquisition cost against the case value it buys
| Measure | National | Bay Area |
|---|---|---|
| Cost per click, full-arch terms | $25 to $50 | $38 to $85 |
| Cost per lead, implants | $107.63 | $160 to $185 |
| Cost per acquisition, full-arch | $1,000 to $2,000 | $1,500 to $3,400 |
| Case value, one arch | $23,500 | $30,550 |
| Case value, both arches | $40K to $60K | $50K to $70K |
Cost per lead of $107.63 is measured account data. Bay Area figures apply the measured 50 to 70 percent San Francisco premium and are therefore estimates.
Published local full-arch pricing, per arch. PCCD publishes nothing, so it is invisible in the comparison patients actually run.
A premium position is still defensible here, but at roughly twice the entry price it now has to be publicly justified rather than simply unstated. Material choice alone moves about $10,000 per arch, since acrylic hybrid and zirconia are different products sold under the same All-on-4 name.
Eighty seven percent of Americans have dental benefits, which sounds like it should matter and does not. The binding constraint is the annual maximum, and it is roughly an order of magnitude too small to touch a full-arch case.
The practical conclusion is that full-arch is a consumer discretionary purchase, so it moves with disposable income and consumer confidence rather than with benefit design.
Maximum loan by lender against the full-arch case range. Only two lenders can fund a full mouth case.
Placement will be done in house. That settles the question this report previously had to leave open, and it changes the economics more than any marketing decision in here. A referred case pays PCCD for the prosthetic work only. An in house case pays for the whole thing.
In house versus referring the surgical phase out. The referral figure assumes PCCD retains the prosthetic portion only, which is an estimate, because no sourced surgical to restorative fee split exists publicly.
Annual gross revenue by monthly arch volume, at $30,550 per arch. Gross case revenue, not margin.
A full mouth case counts as two arches, so three full mouth patients a month is the same as six arches. Because this is a value market rather than a volume market, the realistic path runs through case value and acceptance quality, not through chair count.
With surgery coming in house, three protocol decisions drive both outcomes and the claims PCCD can honestly make. The published evidence is unusually clear on all three.
Implant failure incidence, guided versus freehand, pooled clinical studies
Guided surgery also reduces deviation at the apex and in angulation, which is exactly where freehand drift compounds. The honest counterweight: a 45 patient randomized trial found absolute deviations roughly 1.5 to 3 times worse than the pooled meta-analyses, and static guides tied robotics on platform accuracy. Quote the trial alongside the pooled figures or the advantage looks overstated.
Survival of immediately loaded implants and All-on-4 prostheses
| Measure | Survival |
|---|---|
| Immediately loaded implants, mean weighted | 97.4% |
| Immediate load at 5 years | 97.66% |
| Immediate load at 10 years | 96.94% |
| All-on-4 mandible, 1 year implant level | 99.6% |
| All-on-4 maxilla, 1 year implant level | 98.9% |
| Malo cohort, maxilla at 13 years | 95.7% |
| Malo cohort, mandible at 18 years | 91.7% |
Caveat worth carrying: no adequately powered head to head trial of immediate versus delayed loading in full arch exists. Read this as immediate loading being non inferior in the published record, not as immediate beating delayed. Mandible outperforms maxilla consistently, and smoking is a significant negative predictor.
Prosthetic outcomes by material. The counter-intuitive finding is in the note below.
Zirconia fails rarely but a framework fracture means a full remake, and insufficient vertical space is the leading cause. Acrylic fails often but each failure is a chairside repair. That reframes the zirconia upsell as a maintenance cost argument rather than a survival argument, which is not how it is usually sold. A meta-analysis found no significant difference in implant survival or framework fracture between metal zirconia and metal acrylic, but significantly lower wear and reduced peri-implantitis risk with zirconia.
On a five figure cash purchase in a market where most providers refuse to quote a price, a warranty is the strongest trust instrument available, and it answers the chains on their own terms.
Built on a live Google Ads Keyword Planner forecast for October 2026 across 410 All-on-X terms, targeting Santa Clara, San Mateo and Santa Cruz counties plus the Peninsula cities. The October figures are Google's. The twelve month projection applies the seasonality curve from earlier in this report, and the funnel applies PCCD's own lead handling rates: 50 to 60 percent of leads are reached, and 15 to 20 percent of those reached book a consult.
Read the forecast with two corrections, because both errors push the same way. Google projects a $3.67 cost per click, but published implant keyword costs run $12 to $35 nationally and full-arch terms run $25 to $50, with the San Francisco market carrying a measured 60 percent premium on top. Google also projects a 12.32 percent conversion rate, against a measured 6.3 percent for implant campaigns across 20 accounts. Taken at face value, even with PCCD's own lead handling rates applied, the forecast implies a return of about 31 times, which is not a realistic number for dental paid search. The model below corrects both.
October is Google's forecast. Other months apply the seasonality index, which is modeled rather than measured.
Forecast clicks by geography, October 2026
Santa Clara and San Mateo counties carry 87 percent of the volume. Los Altos itself forecasts under 4 clicks a month and carries the highest city cost per click at $4.76. Targeting PCCD's home city alone would buy almost nothing at the highest price in the set.
| Scenario | CPC | CVR | Clicks | Leads | Reached | Booked | Case starts | Arches | Revenue | CPA | ROAS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A. Forecast exactly as exported | $3.67 | 12.32% | 8,204 | 1,011 | 556 | 97 | 21.9 | 30.6 | $936K | $1,375 | 31x |
| B. Forecast volume, measured conversion | $3.67 | 6.3% | 8,204 | 517 | 284 | 50 | 11.2 | 15.7 | $479K | $2,690 | 16x |
| C. Benchmark cost per click applied | $20.00 | 6.3% | 1,505 | 95 | 52 | 9.1 | 2.05 | 2.87 | $88K | $14,662 | 2.9x |
Funnel held constant across all three, using the midpoint of PCCD's actual rates: 55 percent of leads are reached, 17.5 percent of reached leads book a consult, 75 percent of booked consults show, 30 percent of shown consults start treatment, and 1.4 arches per case at $30,550 per arch. The show and start rates are the earlier planning assumptions, not measured PCCD figures. Only Scenario C uses a realistic cost per click, so it is the planning case.
Traffic is not the constraint. Lead handling is. At PCCD's rates only about one lead in ten becomes a booked consult (55 percent reached times 17.5 percent booked). The earlier version of this model assumed 65 percent, and the commonly cited range is 60 to 75 percent. That single difference moves Scenario C from a $2,171 acquisition cost, inside the published Bay Area full-arch range of $1,500 to $3,400, to $14,662, roughly four to ten times outside it. Same clicks, same leads, same price. The gap is almost entirely what happens after the lead arrives.
Annual case starts in Scenario C, same budget and same leads, changing only the reach and booking rates. The 80 and 35 percent targets are illustrative, not benchmarks.
Low end is 50 percent reached and 15 percent booked. High end is 60 and 20.
| Measure | Low | Mid | High |
|---|---|---|---|
| Leads reached | 47 | 52 | 57 |
| Consults booked | 7.1 | 9.1 | 11.4 |
| Case starts per year | 1.6 | 2.05 | 2.56 |
| Arches per year | 2.2 | 2.9 | 3.6 |
| Revenue | $68K | $88K | $109K |
| Cost per acquisition | $18,817 | $14,662 | $11,761 |
| Return on spend | 2.3x | 2.9x | 3.6x |
Of every 95 leads, about 43 are never reached, and about 43 of the 52 reached never book. Those two leaks are larger than any gain available from bidding or creative.
Annual, from clicks to arches, at benchmark cost per click
Forecast clicks by device, October 2026
Mobile is 78.5 percent of forecast clicks and carries the highest cost per click at $3.82. A full-arch landing page that is not mobile first, with click to call above the fold, is wasting the majority of the budget. Speed to lead compounds this, since conversion falls sharply beyond a five minute response.
What it costs to hit the target. The earlier sections set a realistic ambition of three to five arches a month. At PCCD's current handling rates, four arches a month from paid search would take about 34 case starts a year at a $14,662 acquisition cost, which is roughly $503,000 a year, $41,900 a month, or $1,377 a day. That is about seventeen times the $82.50 daily budget and is not a viable plan. At the forecast budget, paid search produces about three arches a year. With reach at 80 percent and booking at 35 percent, the acquisition cost falls to $5,040 and the same target costs about $173,000 a year, or $14,400 a month. Fix lead handling before scaling spend. Every dollar added at today's rates buys roughly a third of what it would after the fix.
Say that surgery is done in house, and name the credential. Placement is in house, which means PCCD keeps the surgical and the prosthetic side of every case. Nothing on the site says so. This is the single highest leverage change available, because it converts an existing capability into a claim patients can actually find.
Create the full-arch content the market searches. A named program with dedicated pages using All-on-4, All-on-X, full arch and teeth in a day, anchored on the DSD smile preview. This is the cheapest, fastest gap to close.
Publish a starting price and a warranty. Zero of 26 competitors do either. In a category with a weeks long research cycle and three to six consults, this converts trust into appointments and is very hard for a chain to answer.
Fix lead handling before spending more on traffic. Today only about one lead in ten becomes a booked consult, because 50 to 60 percent of leads are reached and 15 to 20 percent of those book. Raising reach to 80 percent and booking to 35 percent roughly triples case starts from the same budget. Respond within five minutes, keep calling past the first attempt, and publish monthly payment examples, which are associated with a 22 percent consultation lift. All of this is operational, not clinical.
Aim at the affluent senior corridor, not the metro. Los Altos Hills, Atherton, Saratoga, Los Altos and Palo Alto carry the age and the money together. Spending against the whole metro wastes the most expensive clicks in the country.
What good looks like. This is a value market, so success is measured in case quality and average case value, not in case counts. A realistic ambition is a named program capturing a modest share of a thin branded supply, at the top of the national price band, in a trade area with 3.9 times the US rate of $200K households. The first milestone is not traffic, it is converting the leads PCCD already gets: at current handling rates the forecast budget yields about three arches a year from paid search.
Corrections to the previous version of this report. Three findings here overturn it. The trade area is younger than the US rather than older, because the earlier comparison was against the county rather than the nation. The edentulism rate should be the education adjusted 8.8 percent rather than a national figure. And the earlier review counts mixed cross platform aggregates with Google counts, which made PCCD look far weaker on reputation than it actually is.